Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Tanja, Peters"'
Autor:
Jörn Grensemann, Emma Möhlenkamp, Philipp Breitfeld, Pischtaz A. Tariparast, Tanja Peters, Mark A. Punke, Stefan Kluge, Martin Petzoldt
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Tracheal intubation in patients with an expected difficult airway may be facilitated by videolaryngoscopy (VL). The VL viewing axis angle is specified by the blade shape and visualization of the larynx may fail if the angle does not meet
Externí odkaz:
https://doaj.org/article/b3d591a064c54b9ebf1b1da96fb2ac22
Autor:
Mélanie Paramananda, Fairouz Smail-Aoudia, Tina Veizovic, Willemijn van der Spuij, Maya Abbas, Gillian Winstanley, Nigel Soanes, Johanna Piper, Esteban Herrero-Martinez, Jean-Christophe Delumeau, Jabeen Ahmad, Tanja Peters
Publikováno v:
Drug Safety
Pharmaceutical legislation provides a legal framework to ensure the safe and effective use of medicines. This framework requires national regulatory authorities (NRAs) to establish and maintain a pharmacovigilance system (PV system) stating and enfor
Autor:
Emma, Möhlenkamp, Eva K, Kohse, Phillip B, Sasu, Tanja, Peters, Jörn, Grensemann, Philipp, Breitfeld, Martin, Petzoldt
Publikováno v:
A&A Practice. 16:e01615
This report describes a patient with Goldenhar syndrome undergoing anesthesia for whom Macintosh videolaryngoscopy failed, as the epiglottis was adhered to the posterior pharynx and could not be lifted with a tracheal introducer (Cormack-Lehane grade
Autor:
Hansjörg Schild, Markus P. Radsak, Philipp Arnold, Pamela Stein, K.D. Lee, Karsten Gogoll, Peter Langguth, Tanja Peters
Publikováno v:
Cellular Immunology. 308:35-43
Imiquimod, a toll-like receptor 7 (TLR7) agonist, is an active pharmaceutical ingredient (API) established for the topical treatment of several dermal cancerous and precancerous skin lesions. Within this work, the immunostimulatory effect of imiquimo
Autor:
Verena Gossen, Markus Albrecht, Tanja Peters, Michael Müller, Arto Valkonen, Kari Rissanen, Andreas Hoffmann, Gerhard Raabe
Publikováno v:
Chemistry – A European Journal. 16:12446-12453
The directionality of interaction of electron-deficient π systems with spherical anions (e.g,. halides) can be controlled by secondary effects like NH or CH hydrogen bonding. In this study a series of pentafluorophenyl-substituted salts with polyhal
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 372:291-299
Monastrol is the first characterised small molecule inhibitor of the motor protein Eg5 involved in bipolar mitotic spindle assembly. Eg5 localises to microtubules in mitosis, but not to interphase microtubules, suggesting that Eg5 inhibitors may be u
Autor:
Tanja Peters, Andreas Kovar, Sonja Kroesser, Thomas Machnig, Venkatesh Atul Bhattaram, Nelamangala V. Nagaraja, Hartmut Derendorf
Publikováno v:
The Journal of Clinical Pharmacology. 45:631-639
Eniporide (EMD 96 875) is a novel and selective inhibitor of the Na+-H+ exchange (NHE-1) inhibitor. The study objectives were to identify a structural model for population pharmacokinetic analysis of eniporide and its metabolite (EMD 112 843) using n
Autor:
Tanja, Peters, Catrin, Grunewald, Matthias, Blaickner, Markus, Ziegner, Christian, Schütz, Dorothee, Iffland, Gabriele, Hampel, Thomas, Nawroth, Peter, Langguth
Publikováno v:
Radiation Oncology (London, England)
Background Neutron capture therapy for glioblastoma has focused mainly on the use of 10B as neutron capture isotope. However, 157Gd offers several advantages over boron, such as higher cross section for thermal neutrons and the possibility to perform
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 94
The [ 18 F]fluoroethyl moiety has been widely utilized in the synthesis of 18 F-labelled compounds. The aim of this work was the reliable synthesis of [ 18 F]FEtOTf with a novel strategy to increase the reactivity of the commonly used [ 18 F]FEB and
Publikováno v:
The Journal of Clinical Pharmacology. 41:139-148
The aim of this study was to investigate the pharmacokinetics and pharmacodynamics of the new cardioprotective sodium/proton exchange (NHE-1) inhibitor eniporide in humans. Eniporide was administered intravenously to healthy volunteers in doses betwe